Lawriter - OAC - 3344-48-03 Implementation of the program.

3344-48-03 Implementation of the program.

(A) Time frame: testing shall occur regularly during the academic year. Student-athletes shall be randomly selected for testing.

(B) Substances: the screening of substances may include, but is not limited to, the following:

(1) Amphetamines (including ecstasy)

(2) Anabolic steroids (HGH, syndopharb)

(3) Barbituates

(4) Cocaine

(5) Methaqualone

(6) Opiates (including heroin)

(7) PCP (angel dust) and analogues

(8) Tetrahydrocannabinol (THC, marijuana, synthetic marijuana)

(9) Alcohol

(10) Tobacco

(C) Many of the substances above are found in dietary and herbal supplements. The CSU department of athletics and its personnel, in accordance with NCAA regulations, shall not distribute or encourage the use of any dietary supplements or ergogenic aids.

(D) Often, labeling of dietary supplements is not accurate and is misleading. Dietary supplements are not regulated by the food and drug administration (FDA) and, therefore, their purity is questionable.

(E) The use of dietary supplements may result in a positive drug test. Student-athletes who choose to use dietary supplements are encouraged to review the supplement with a member of the sports medicine department. Student-athletes are also encouraged to contact the national center for drug free sport, inc., at 877-202-0769 or using the passcode NCAA1. Ultimate responsibility and accountability belongs to the student-athlete.

(F) Selection: student-athletes shall be selected through a random selection program. Since the process is totally random, it is possible that the same individual may be selected on numerous occasions.

(G) Individuals who exhibit behavior symptomatic of drug usage may be selected independently of the random sample. A reasonable suspicion testing form may be completed by any concerned athletic department employee and reviewed with a member of the athletic training staff and/or head team physician or his/her designee. Any other university official or faculty member may bring his/her concerns about individual student-athletes to a member of the athletic training staff for discussion in consultation with the head team physician or his/her designee.

(H) There may be occasions where collaboration between the head team physician, head athletic trainer, head coach, and sport supervisor suggests the testing of an entire team. Under such circumstance, specific testing will not be randomized, but rather all-inclusive.

(I) All other implementation procedures, notifications, and reporting of results shall be handled according to this policy.

(1) Post-season/championship screening: Any participant or team likely to advance to post season championship competition may be subject to additional testing. Testing may be required of all team members or individual student-athletes at any time within thirty days prior to the postseason competition. If a student-athlete tests positive, they shall not be allowed to compete for the duration of the championship season and shall be subject to sanctions, herein.

(2) Re-entry testing: a student-athlete who has had his or her eligibility to participate in intercollegiate sports suspended as a result of a drug and alcohol violation may be required to undergo re-entry drug and/or alcohol testing prior to regaining eligibility. The director of athletics or the designee for the director of athletics shall arrange for reentry testing after the counselor or specialist involved in the student-athlete's case indicates that re-entry into the intercollegiate sports program is appropriate.

(3) Follow-up testing: A student-athlete who has returned to participation in intercollegiate sports following a positive drug test under this policy, may be subject to follow-up testing. Testing shall be unannounced and shall be required at a frequency determined by the athletic director or the designee of the athletic director in consultation with the counselor or specialist involved in the student-athlete's case.

(4) Pre-season screening: student-athletes are subject to preseason drug testing and may be notified of such by the director of athletics or designee of the athletic director at any time prior to their first competition.

(5) Transfer students: if it is brought to the attention of any sports medicine or Cleveland state university staff that a student-athlete transferring into Cleveland state university has history with prior positive drug test results with another university or with the NCAA, the student-athlete may be evaluated by the head team physician or authorized designee and may be submitted to non-random testing. However, no prior test results shall be considered as a first or subsequent positive test result for the purpose of the Cleveland state university drug education and screening program policy.

(6) Notification: the student-athlete shall be notified of his/her selection for drug screening by a member of the CSU sports medicine staff. This notification can occur at any time. At the time of notification, the student-athlete shall be presented with a student-athlete notification form, which indicates the date, time, and testing area. This form shall be signed and dated by the sports medicine staff member and the student-athlete. Failure of the student-athlete to sign the form indicates an unwillingness to participate in the program and serves as a positive test result. Any refusal to participate in a required drug test, including not providing an adequate sample, leaving the testing area before providing an adequate sample, or failing to appear at the time of testing for any reason, shall be treated as a positive test and shall result in the penalties outlined in the CSU drug education and screening program policy.

Replaces: 3344-48-03

Effective: 3/9/2015
Promulgated Under: 111.15
Statutory Authority: 111.15
Rule Amplifies: 3344
Prior Effective Dates: 4/13/06, 2/17/14.